Search | IOVS | ARVO Journals

View

Showing 1 – 2 of 2

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma January 2018

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent

PDF

Tomoko Kirihara; Takazumi Taniguchi; Kenzo Yamamura; Ryo Iwamura; Kenji Yoneda; Noriko Odani-Kawabata; Atsushi Shimazaki; Takeshi Matsugi; Naveed Shams; Jin-Zhong Zhang
TAGS: agonists, antihypertensive agents, intraocular pressure, pharmacology, prostaglandins
Invest. Ophthalmol. Vis. Sci.. 2018; 59(1):145-153. doi: https://doi.org/10.1167/iovs.17-22745

ARVO Annual Meeting Abstract June 2017

Pharmacokinetics, Safety and IOP Lowering Profiles of omidenepag isopropyl, a Selective EP2 Agonist in Healthy Japanese and Caucasian Volunteers (Phase I Study)

Makoto Aihara; Fenghe Lu; Hisashi Kawata; Yuki Tanaka; Kenzo Yamamura; Ryo Iwamura; Kenji Yoneda; Noriko Odani; Naveed Shams

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2104. doi:

Advertisement